Mr. Speaker, I thank my colleague for his question.
I lean more toward the motion as presented than to the Danish example. This example is one of the things that has stirred up a great deal of comment from all countries, even one study. The European Commission has struck a European Food Safety Authority Scientific Panel on Dietetic Products, Nutrition and Allergies and mandated it to produce an opinion on the presence of trans fats in foods for human consumption. This was done because the opinion of the EU member states on this differed from that of the Danish authorities.
The Danish government used public health as the basis of its argument to justify passage of this legislation. It claims there is a fairly clear connection between the consumption of trans fats and cardiovascular disease, stroke, certain types of cancer and type 2 diabetes. Yesterday we met some young people who have type 1 diabetes, but type 2 we know can be remedied. That is very important.
In my opinion, the NDP motion is both important and of great interest.